Radiation-therapy developer Proxima Therapeutics said the first patient in Canada has been treated with its catheter-based radiation treatment device, MammoSite RTS. The device was implanted under a protocol developed at the Ville Marie Oncology Center and the Centre Hospitalier de l'Université de Montréal.
MammoSite RTS internally delivers radiation directly to the tissue surrounding a tumor, thus minimizing radiation exposure to healthy tissue, according to the Alpharetta, GA-based firm. The device received clearance from Health Canada’s Therapeutic Products Programme in August 2001 and the U.S. Food and Drug Administration in May 2002.
By AuntMinnie.com staff writersSeptember 17, 2003
Related Reading
Proxima is cleared for MammoSite RTS, May 7, 2002
Copyright © 2003 AuntMinnie.com
